BITGF (Biotage AB) Additional Paid-In Capital : $226.3 Mil(As of Mar. 2025)

View and export this data going back to 2010. Start your Free Trial

What is Biotage AB Additional Paid-In Capital?

Biotage AB's quarterly additional paid-in capital declined from Sep. 2024 ($223.9 Mil) to Dec. 2024 ($208.6 Mil) but then increased from Dec. 2024 ($208.6 Mil) to Mar. 2025 ($226.3 Mil).

Biotage AB's annual additional paid-in capital increased from Dec. 2022 ($27.1 Mil) to Dec. 2023 ($223.3 Mil) but then declined from Dec. 2023 ($223.3 Mil) to Dec. 2024 ($208.6 Mil).

Biotage AB Additional Paid-In Capital Historical Data

The historical data trend for Biotage AB's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Additional Paid-In Capital Chart

Biotage AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Additional Paid-In Capital

Get a 7-Day Free Trial

7.17

29.26

27.08

223.35

208.56

Biotage AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Additional Paid-In Capital	Get a 7-Day Free Trial															219.86	218.27	223.87	208.56	226.30

Biotage AB Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Biotage AB Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Biotage AB's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotage AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OTCPK:BITGF) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

BIOT:Sweden BIOTs:UK 0GRP:UK PQX1:Germany

Address

Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03

Website

https://www.biotage.com

Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.